Therefore, our data in both acquired and intrinsically venetoclax-resistant DLBCL lines significantly extend and strengthen the conclusion that changes in mitochondrial oxidative phosphorylation regulate venetoclax sensitivity and highlight the critical role of the IDH2 pathway in DLBCL venetoclax resistance. The gene discussed is IDH2; the disease is diffuse large B-cell lymphoma.